Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rou-Chen Shen"'
Autor:
Ching-Yuan Wu, Yao-Hsu Yang, Yu-Shih Lin, Li-Hsin Shu, Yu-Ching Cheng, Hung-Te Liu, Yin-Yin Lin, I-Yun Lee, Wei-Tai Shih, Pei-Rung Yang, Ying-Ying Tsai, Geng-He Chang, Cheng-Ming Hsu, Reming-Albert Yeh, Yu-Huei Wu, Yu-Heng Wu, Rou-Chen Shen, Ming-Shao Tsai
Publikováno v:
Heliyon, Vol 9, Iss 7, Pp e17701- (2023)
The Chiehyuan herbal oral protection solution (GB-2) is a herbal mixture commonly utilized in Taiwan for combating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as per traditional Chinese medicine practices. This study assessed the cli
Externí odkaz:
https://doaj.org/article/fc97a609e45b4c75be5198532329e643
Autor:
Ming-Shao Tsai, Wei-Tai Shih, Yao-Hsu Yang, Yu-Shih Lin, Geng-He Chang, Cheng-Ming Hsu, Reming-Albert Yeh, Li-Hsin Shu, Yu-Ching Cheng, Hung-Te Liu, Yu-Huei Wu, Yu-Heng Wu, Rou-Chen Shen, Ching-Yuan Wu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 149, Iss , Pp 112802- (2022)
At the time of writing, more than 440 million confirmed coronavirus disease 2019 (COVID-19) cases and more than 5.97 million COVID-19 deaths worldwide have been reported by the World Health Organization since the start of the outbreak of the pandemic
Externí odkaz:
https://doaj.org/article/ef40ff5ea74349959210b52b67a1624d
GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2
Autor:
Ming-Shao Tsai, Yao-Hsu Yang, Yu-Shih Lin, Geng-He Chang, Cheng-Ming Hsu, Reming-Albert Yeh, Li-Hsin Shu, Yu-Ching Cheng, Hung-Te Liu, Yu-Huei Wu, Yu-Heng Wu, Rou-Chen Shen, Ching-Yuan Wu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 142, Iss , Pp 112011- (2021)
Since the start of the outbreak of coronavirus disease 2019 in Wuhan, China, there have been more than 150 million confirmed cases of the disease reported to the World Health Organization. The beta variant (B.1.351 lineage), the mutation lineages of
Externí odkaz:
https://doaj.org/article/edeb9d6ea1aa438db3df9942a1b34eb1
GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2
Autor:
Yu-Shih Lin, Chang Geng-He, Wu Ching-Yuan, Li-Hsin Shu, Cheng-Ming Hsu, Yao-Hsu Yang, Yu-Heng Wu, Ming-Shao Tsai, Yu-Huei Wu, Yu-Ching Cheng, Reming-Albert Yeh, Hung-Te Liu, Rou-Chen Shen
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 142, Iss, Pp 112011-(2021)
Biomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy
Since the start of the outbreak of coronavirus disease 2019 in Wuhan, China, there have been more than 150 million confirmed cases of the disease reported to the World Health Organization. The beta variant (B.1.351 lineage), the mutation lineages of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b8b5718aedf022bf1c4712f6d0b9d96
http://www.sciencedirect.com/science/article/pii/S0753332221007940
http://www.sciencedirect.com/science/article/pii/S0753332221007940